{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T06:47:28Z","timestamp":1763016448355},"reference-count":31,"publisher":"Elsevier BV","issue":"11-12","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.vaccine.2003.10.026","type":"journal-article","created":{"date-parts":[[2003,12,6]],"date-time":"2003-12-06T11:47:31Z","timestamp":1070711251000},"page":"1406-1414","source":"Crossref","is-referenced-by-count":21,"title":["Persistence of antibodies at 5\u20136 years of age for children who had received a primary series vaccination with a pentavalent whole-cell pertussis vaccine and a first booster with a pentavalent acellular pertussis vaccine: immunogenicity and tolerance of second booster with a tetravalent acellular vaccine at 5\u20136 years of age"],"prefix":"10.1016","volume":"22","author":[{"given":"Jacques","family":"Langue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"No\u00eblle","family":"Matisse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Pacoret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Undreiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Boisnard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beno\u0131\u0302t","family":"Soubeyrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2003.10.026_BIB1","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0929-693X(97)83413-6","article-title":"Epidemiological estimate of anti-pertussis vaccination efficacy during epidemics in community [Estimation \u00e9pid\u00e9miologique de l\u2019efficacit\u00e9 de la vaccination anticoquelucheuse au cours d\u2019\u00e9pid\u00e9mies en collectivit\u00e9]","volume":"4","author":"Baron","year":"1997","journal-title":"Arch. P\u00e9diatr."},{"key":"10.1016\/j.vaccine.2003.10.026_BIB2","unstructured":"Avis du conseil sup\u00e9rieur d\u2019hygi\u00e8ne publique de France du 13 mars 1998. Calendrier vaccinal 1998. Bulletin Epid\u00e9miologique Hebdomadaire 1998; No. 15."},{"key":"10.1016\/j.vaccine.2003.10.026_BIB3","unstructured":"La Vaccination contre la Coqueluche des nourrissons. Avis du Conseil Sup\u00e9rieur d\u2019Hygi\u00e8ne Publique de France. Bulletin Epid\u00e9miologique Hebdomadaire 2001; No. 19."},{"key":"10.1016\/j.vaccine.2003.10.026_BIB4","unstructured":"Langue J, David T, Roussel F, Pines E, Hoffenbach A. Safety and immunogenicity of DTaP-IPV and Act-Hib(tm) vaccines administered either combined or separately to infants at 2, 3 and 4 months of age. In: 15th Annual Meeting of European Society for Paediatric Infectious Diseases in Paris; 1997 [Abstract]."},{"key":"10.1016\/j.vaccine.2003.10.026_BIB5","unstructured":"Mallet E, Hoffenbach A, Pines E, Salomon H. Immunogenicity of the fourth dose of a combined DTaP-IPV\/Act-Hib(tm) vaccine administered at 15 months of age to children primed either at 2, 3, and 4 or at 2, 4, and 6 months of age. In: 15th Annual Meeting of European Society for Paediatric Infectious Diseases in Paris; 1997 [Abstract]."},{"key":"10.1016\/j.vaccine.2003.10.026_BIB6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00006454-200206000-00011","article-title":"Antibody persistence in five-year-old children who received a pentavalent combination vaccine in infancy","volume":"21","author":"Carlsson","year":"2002","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2003.10.026_BIB7","unstructured":"David T, Cadoz M, Gobert T, et al. Comparison to a DTP-IPV with a whole-cell pertussis component in infants. In: 31st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago; 29 September to 2 October 1991 [Abstract]."},{"key":"10.1016\/j.vaccine.2003.10.026_BIB8","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/BF01690510","article-title":"Comparative safety and immunogenicity of an acellular versus whole-cell pertussis component of diphtheria\u2013tetanus\u2013pertussis vaccines in senegalese infants","volume":"15","author":"Simondon","year":"1996","journal-title":"Eur. J. Microbiol. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.10.026_BIB9","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1542\/peds.96.3.548","article-title":"Comparison of 13 acellular pertussis vaccines: overview and serologic response","volume":"96","author":"Edwards","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2003.10.026_BIB10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0264-410X(92)90413-E","article-title":"Dose-response to acellular pertussis vaccine and comparison with whole cell pertussis vaccine at 15-24 months and 4-6 years of age","volume":"10","author":"Auerbach","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.10.026_BIB11","unstructured":"Miller E, Miller DL, Ashworth LAE, Waight PA, Harbert K. Comparison of antibody responses and symptoms following primary immunisation with British whole-cell and three acellular DTP Vaccines. In: Manclark CR, editor. Proceedings of the Sixth International Symposium on Pertussis, Bethesda, Maryland: (FDA) 90-1164; 1990. p. 303\u201310."},{"key":"10.1016\/j.vaccine.2003.10.026_BIB12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00006454-199104000-00010","article-title":"Booster response to acellular pertussis vaccine in children primed with acellular or whole-cell vaccines","volume":"10","author":"Edwards","year":"1991","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2003.10.026_BIB13","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/infdis\/160.5.832","article-title":"Evaluation of a new highly purified pertussis vaccine in infants and children","volume":"160","author":"Edwards","year":"1989","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.10.026_BIB14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/infdis\/168.1.15","article-title":"Acellular pertussis vaccines\u2013a solution to the pertussis problem?","volume":"168","author":"Edwards","year":"1993","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.10.026_BIB15","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1542\/peds.96.3.557","article-title":"Comparison of 13 acellular pertussis vaccines: adverse reactions","volume":"96","author":"Decker","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2003.10.026_BIB16","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/infdis\/170.4.873","article-title":"Outcomes of Bordetella pertussis infection in different age groups of an immunized population","volume":"170","author":"He","year":"1994","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.10.026_BIB17","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.1128\/IAI.69.7.4516-4520.2001","article-title":"Long-term pertussis-specific immunity after primary vaccination with a combined diphtheria, tetanus, tricomponent acellular pertussis, and hepatitis B vaccine in comparison with that after natural infection","volume":"69","author":"Esposito","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.10.026_BIB18","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1128\/JCM.20.4.772-774.1984","article-title":"Immunoenzymatic assay of anti-diphteria toxin antributes in human serum","volume":"20","author":"Camargo","year":"1984","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2003.10.026_BIB19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0092-1157(83)80038-9","article-title":"A comparison of enzyme linked immunosorbent assay (ELISA) with the toxin neutralisation test in mice as a method for the estimation of tetanus antitoxin in human sera","volume":"11","author":"Melville-Smith","year":"1983","journal-title":"J Biol Stand"},{"key":"10.1016\/j.vaccine.2003.10.026_BIB20","unstructured":"Manclark CR, Meade BD, Burstyn DB. Serological response to bordetella pertusis. In: Rose NR, Friedman H, Fahey JL, editors. Manual of clinical laboratory immunology. 3rd ed. Washington, DC: American Society for Microbiological; 1986. p. 388\u201394."},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2003.10.026_BIB21","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/clinids\/6.Supplement_2.S545","article-title":"Seroimmunity following vaccination in infants by an inactivated poliovirus vaccine prepared on Vero cells","volume":"6","author":"Grenier","year":"1984","journal-title":"Rev. infect. Dis."},{"key":"10.1016\/j.vaccine.2003.10.026_BIB22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/infdis\/103.3.239","article-title":"A quantitative immunochemical measure of the primary interaction between I* BSA and antibody","volume":"103","author":"Farr","year":"1958","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.10.026_BIB23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00006454-200101000-00013","article-title":"Immunologic correlates of protection induced by vaccination","volume":"20","author":"Plotkin","year":"2001","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2003.10.026_BIB24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1128\/CDLI.3.1.93-97.1996","article-title":"Long-term human serum antibody responses after immunisation with whole-cell pertussis vaccine in France","volume":"3","author":"Grimprel","year":"1996","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.vaccine.2003.10.026_BIB25","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1086\/315509","article-title":"Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine","volume":"181","author":"Ausiello","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.10.026_BIB26","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/S0140-6736(99)01576-7","article-title":"Influence of vaccination coverage on pertussis transmission in France","volume":"354","author":"Grimprel","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2003.10.026_BIB27","unstructured":"Guiso N, B\u00e9gu\u00e9 P, Cohen R, Gaudelus J, Olivier C, Vie le Sage F, et al. Comparison of pertussis antibody levels in children up to 5 years of age primed at 2, 3, 4 months and boostered in the second year of life with either DTPa or DTPw based combination vaccines, in France. In: 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, 17\u201320 September 2000 [Abstract]."},{"key":"10.1016\/j.vaccine.2003.10.026_BIB28","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1128\/JCM.38.2.800-806.2000","volume":"38","author":"De Melker","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.vaccine.2003.10.026_BIB29","unstructured":"Danjou G, Silier T, Dupuy M. Comparison of DTacP-IPV vaccine with DTP-IPV (TETRACOQ(tm)) vaccine administered as a second booster at 4 to 7 years of age. In: 15th Annual Meeting of European Society for Paediatric Infectious Diseases, Paris, 22\u201323 May 1997 [Abstract]."},{"key":"10.1016\/j.vaccine.2003.10.026_BIB30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.107.2.e25","article-title":"Reactogenicity and immunogenicity at preschool age of a booster dose of two three-component diphtheria\u2013tetanus\u2013acellular pertussis vaccines in children primed in infancy with acellular vaccines","volume":"107","author":"Tozzi","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2003.10.026_BIB31","first-page":"62","article-title":"Adverse reactions and serologic response to a booster dose of acellular pertussis vaccine in children immunized with acellular or whole-cell vaccine as infants","volume":"84","author":"Blennow","year":"1989","journal-title":"Pediatrics"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03007746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03007746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T15:59:18Z","timestamp":1682611158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X03007746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":31,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0264410X03007746"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2003.10.026","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}